These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10445666)

  • 1. Cocaine and methamphetamine abuse are primary focus of new guidelines for treating stimulant use disorders.
    Psychiatr Serv; 1999 Aug; 50(8):1099-100. PubMed ID: 10445666
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best-practice guidelines focus on collaboration between criminal justice and substance abuse treatment systems.
    Psychiatr Serv; 1999 May; 50(5):717. PubMed ID: 10332917
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of substance abuse in the hospital setting.
    Gist RS; Sullivan M; Serianni RP
    Int Anesthesiol Clin; 2011; 49(1):15-30. PubMed ID: 21239903
    [No Abstract]   [Full Text] [Related]  

  • 5. A case-matched comparison of readmission patterns between primary methamphetamine-using and primary cocaine-using adolescents engaged in inpatient substance-abuse treatment.
    Callaghan R; Taylor L; Victor JC; Lentz T
    Addict Behav; 2007 Dec; 32(12):3101-6. PubMed ID: 17618062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: racial differences and the impact of methamphetamine legislation.
    Borders TF; Booth BM; Han X; Wright P; Leukefeld C; Falck RS; Carlson RG
    Addiction; 2008 May; 103(5):800-8. PubMed ID: 18412758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical characteristics of adolescents reporting methamphetamine as their primary drug of choice: an examination of youth admitted to inpatient substance-abuse treatment in northern British Columbia, Canada, 2001-2005.
    Callaghan RC; Brands B; Taylor L; Lentz T
    J Adolesc Health; 2007 Mar; 40(3):286-9. PubMed ID: 17321434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine and cocaine users: differences in characteristics and treatment retention.
    Rawson R; Huber A; Brethen P; Obert J; Gulati V; Shoptaw S; Ling W
    J Psychoactive Drugs; 2000; 32(2):233-8. PubMed ID: 10908013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Looking for help...the experience of residential drug treatment.
    Gardner D
    Health PAC Bull; 1993; 23(3):9-11. PubMed ID: 10171779
    [No Abstract]   [Full Text] [Related]  

  • 10. Ice--a new drug of concern?
    Beebe DK; Walley EJ
    J Miss State Med Assoc; 1994 Aug; 35(8):225-7. PubMed ID: 7932687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].
    Thomasius R; Gouzoulis-Mayfrank E; Karus C; Wiedenmann H; Hermle L; Sack PM; Zeichner D; Küstner U; Schindler A; Krüger A; Uhlmann S; Petersen KU; Zapletalova P; Wartberg L; Schütz CG; Schulte-Markwort M; Obrocki J; Heinz A; Schmoldt A;
    Fortschr Neurol Psychiatr; 2004 Dec; 72(12):679-95. PubMed ID: 15580533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulant abuse treatment and HIV.
    Siever MD
    Focus; 1998 Mar; 13(4):4-6. PubMed ID: 11365172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practitioners' attitudes concerning evidence-based guidelines in Belgian substance abuse treatment.
    Autrique M; Vanderplasschen W; Broekaert E; Sabbe B
    Eur Addict Res; 2009; 15(1):47-55. PubMed ID: 19052462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearinghouse: stimulants and HIV.
    Focus; 1998 Mar; 13(4):4-5. PubMed ID: 11365171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The matrix model of outpatient stimulant abuse treatment: history and description.
    Obert JL; McCann MJ; Marinelli-Casey P; Weiner A; Minsky S; Brethen P; Rawson R
    J Psychoactive Drugs; 2000; 32(2):157-64. PubMed ID: 10908003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the self-report of recent cocaine or methamphetamine use reliable in illicit stimulant drug users who present to the Emergency Department with chest pain?
    Lee MO; Vivier PM; Diercks DB
    J Emerg Med; 2009 Aug; 37(2):237-41. PubMed ID: 19081702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Center of excellence' can improve the quality of substance abuse services.
    Provet P
    Behav Healthc Tomorrow; 2003 Aug; 12(4):12-6, 18. PubMed ID: 12926297
    [No Abstract]   [Full Text] [Related]  

  • 18. Cocaine and methamphetamine: differential addiction rates.
    Gonzalez Castro F; Barrington EH; Walton MA; Rawson RA
    Psychol Addict Behav; 2000 Dec; 14(4):390-6. PubMed ID: 11130157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An tale of two epidemics: HIV and stimulant use.
    Gorman M
    Focus; 1998 Mar; 13(4):1-3. PubMed ID: 11365170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine abusers in therapeutic community treatment.
    De Leon G
    NIDA Res Monogr; 1993; 135():163-89. PubMed ID: 8289896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.